These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 38596688)
1. Differences in F pocket impact on HLA I genetic associations with autoimmune diabetes. Ren X; Amarajeewa AWP; Jayasinghe MDT; Garstka MA Front Immunol; 2024; 15():1342335. PubMed ID: 38596688 [TBL] [Abstract][Full Text] [Related]
2. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications. Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882 [TBL] [Abstract][Full Text] [Related]
3. Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes. Sharma R; Amdare NP; Ghosh A; Schloss J; Sidney J; Garforth SJ; Lopez Y; Celikgil A; Sette A; Almo SC; DiLorenzo TP J Biol Chem; 2024 Sep; 300(9):107702. PubMed ID: 39173948 [TBL] [Abstract][Full Text] [Related]
4. Polymorphism in F pocket affects peptide selection and stability of type 1 diabetes-associated HLA-B39 allotypes. Amarajeewa AWP; Özcan A; Mukhtiar A; Ren X; Wang Q; Ozbek P; Garstka MA; Serçinoğlu O Eur J Immunol; 2024 Jun; 54(6):e2350683. PubMed ID: 38549458 [TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas. Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013 [TBL] [Abstract][Full Text] [Related]
6. Circulating β cell-specific CD8 Yeo L; Pujol-Autonell I; Baptista R; Eichmann M; Kronenberg-Versteeg D; Heck S; Dolton G; Sewell AK; Härkönen T; Mikk ML; Toppari J; Veijola R; Knip M; Ilonen J; Peakman M Clin Exp Immunol; 2020 Mar; 199(3):263-277. PubMed ID: 31660582 [TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Valdes AM; Erlich HA; Noble JA Hum Immunol; 2005 Mar; 66(3):301-13. PubMed ID: 15784469 [TBL] [Abstract][Full Text] [Related]
8. The HLA A03 Supertype and Several de Groot NG; Heijmans CMC; de Ru AH; Otting N; Koning F; van Veelen PA; Bontrop RE J Virol; 2020 Apr; 94(9):. PubMed ID: 32075930 [TBL] [Abstract][Full Text] [Related]
9. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes. Harfouch-Hammoud E; Walk T; Otto H; Jung G; Bach JF; van Endert PM; Caillat-Zucman S Diabetes; 1999 Oct; 48(10):1937-47. PubMed ID: 10512357 [TBL] [Abstract][Full Text] [Related]
10. HLA Allele-Specific Quantitative Profiling of Type 1 Diabetic B Lymphocyte Immunopeptidome. Sudhir PR; Lin TD; Zhang Q J Proteome Res; 2022 Jan; 21(1):250-264. PubMed ID: 34932366 [TBL] [Abstract][Full Text] [Related]
11. Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and Mishto M; Mansurkhodzhaev A; Rodriguez-Calvo T; Liepe J Front Immunol; 2021; 12():656451. PubMed ID: 33936085 [TBL] [Abstract][Full Text] [Related]
12. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710 [TBL] [Abstract][Full Text] [Related]
13. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes. Bordner AJ; Mittelmann HD BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497 [TBL] [Abstract][Full Text] [Related]
14. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Cucca F; Lampis R; Congia M; Angius E; Nutland S; Bain SC; Barnett AH; Todd JA Hum Mol Genet; 2001 Sep; 10(19):2025-37. PubMed ID: 11590120 [TBL] [Abstract][Full Text] [Related]
15. Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. Brims DR; Qian J; Jarchum I; Mikesh L; Palmieri E; Ramagopal UA; Malashkevich VN; Chaparro RJ; Lund T; Hattori M; Shabanowitz J; Hunt DF; Nathenson SG; Almo SC; Dilorenzo TP Int Immunol; 2010 Mar; 22(3):191-203. PubMed ID: 20093428 [TBL] [Abstract][Full Text] [Related]
16. Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes. Park Y Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S19-25. PubMed ID: 15563974 [TBL] [Abstract][Full Text] [Related]
17. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans. Serreze DV; Niens M; Kulik J; DiLorenzo TP Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089 [TBL] [Abstract][Full Text] [Related]
18. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. Ettinger RA; Papadopoulos GK; Moustakas AK; Nepom GT; Kwok WW J Immunol; 2006 Feb; 176(3):1988-98. PubMed ID: 16424231 [TBL] [Abstract][Full Text] [Related]
19. Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes. Olson E; Ceccarelli T; Raghavan M Elife; 2023 Feb; 12():. PubMed ID: 36722462 [TBL] [Abstract][Full Text] [Related]
20. Selection, engineering, and in vivo testing of a human leukocyte antigen-independent T-cell receptor recognizing human mesothelin. Hiscox MJ; Wasmuth A; Williams CL; Foot JN; Wiedermann GE; Fadda V; Boiani S; Cornforth TV; Wikiert KA; Bruton S; Cartwright N; Anderson VE; Barnes CS; Vieira JV; Birch-Machin I; Gerry AB; Miller K; Pumphrey NJ PLoS One; 2024; 19(4):e0301175. PubMed ID: 38574067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]